Skip to main content
. 2017 Mar 22;31(7):2916–2924. doi: 10.1096/fj.201700001R

Figure 6.

Figure 6.

CRMP treatment ameliorates liver inflammation and markers of apoptosis. AC) Plasma aspartate aminotransferase (AST) (A), alanine aminotransferase (ALT) (B), and alkaline phosphatase (ALP) (C) concentrations. DF) Hepatic protein expression of several proinflammatory and anti-inflammatory markers (D), CD69 (E), and caspase 3 (F). Data are means ± sem (n = 6–8 per group). Statistical significance was determined by Student’s t test. **P < 0.01.